Live Breaking News & Updates on Poseida Board

Stay updated with breaking news from Poseida board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic engineering technologies Astellas to invest a total of $50 million to acquire approximately 8.8% of Poseida and to receive a right of exclusive negotiation and first refusal for any potential partnering of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy product candidate for solid tumors Astellas will have the right to designate an obser. ....

Naoki Okamura , Mark Gergen , Adam Pearson , Poseida Therapeutics Inc , Exchange Commission , Astellas Pharma Inc , Support Poseida , Redefining Cancer Cell , Poseida Board , Poseida Therapeutics , Focus Area Approach , Astella Primary Focuses , Chief Strategy Officer , Chief Executive , Site Specific Gene Editing , Looking Statements , Private Securities Litigation Reform Act , Press Release Image , Clinical Stage , P Muc1c Allo1 , Ar T , Press Release , Ews Release ,

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic engineering technologies
Astellas to invest a. ....

Mark Gergen , Adam Pearson , Naoki Okamura , Exchange Commission , Prnewswire Astellas Pharma Inc , Astellas Pharma Inc , Poseida Therapeutics Inc , Poseida Board , Poseida Therapeutics , Focus Area Approach , Astella Primary Focuses , Chief Strategy Officer , Chief Executive , Site Specific Gene Editing System , Looking Statements , Private Securities Litigation Reform Act ,

Poseida Therapeutics (PSTX) Announces Board Changes

Poseida Therapeutics (PSTX) Announces Board Changes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark Gergen , Eric Ostertag , Transposagen Biopharmaceuticals Inc , University Of Pennsylvania , Poseida Therapeutics Inc , Executive Chairman , Poseida Board , Chief Executive Officer , Transposagen Biopharmaceuticals , Investigational New Drug ,

Poseida Therapeutics Announces Board Change

/PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with. ....

Mark Gergen , Eric Ostertag , Transposagen Biopharmaceuticals Inc , University Of Pennsylvania , Poseida Therapeutics Inc , Prnewswire Poseida Therapeutics Inc , Executive Chairman , Poseida Board , Chief Executive Officer , Transposagen Biopharmaceuticals , Investigational New Drug , Poseida Therapeutics , Site Specific Gene Editing System ,